The second annual OMH Symposium will be held at the Medical Sciences Teaching Centre, South Parks Road, on Monday 1 July 2019 showcasing a diverse range of world-leading research from across Oxford on topics including circadian physiology, cancer metabolism, and the role of immune cells in metabolic disease. Further details about the programme will be available shortly. Abstracts for posters presented elsewhere or for new work are welcome. Further details about how to submit an abstract are available here.
Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Antimicrobial Resistance, taking place on Thursday 4 July 2019 at the Blavatnik School of Government.
Mathematical modelling, particularly when combined with economical modelling, allows researchers and policy makers to determine the most effective interventions to fight infectious diseases such as malaria. We can use those models to explore ‘what ifs’ scenarios, at country or province level, saving more lives and limiting costs. Prof Lisa White, head of the Mathematical and Economic Modelling (MAEMOD) group based in Bangkok, MORU, explains in this recent podcast.
Eight Oxford scientists are amongst 50 of the UK's world-leading researchers elected to join the prestigious Fellowship of the Academy of Medical Sciences this year including from NDM: Professors Philip Bejon, Helen McShane, Richard Price, Alison Simmons and Sarah Walker. Many congratulations to you all!
Congratulations to Ludwig Oxford’s Mads Gyrd-Hansen, whose Senior Research Fellowship has been renewed by the Wellcome Trust. This > £1 million 5 year award will support the continuation of his research into ubiquitin signalling in immune responses. The Gyrd-Hansen group will build on their previous investigations into the enzyme complex, LUBAC, which joins together ubiquitin molecules so that they form linear chains.
Hepatitis B virus (HBV) infects 290 million people worldwide. Oxford Nanopore Technology sequencing platforms provide potential for sequencing the whole HBV genome in a single read, facilitating improved insights into virus epidemiology, diversity, and pathogenesis. Dr Anna McNaughton and fellow researchers from the Translational Gastroenterology Unit have developed laboratory and bioinformatic methods enabling accurate HBV sequencing using the Nanopore platform
Thursday 23rd May 2019 , 1 - 2 pm
Lecture Theatre 1
Chair: Prof Chris ConlonView upcoming medical grand rounds